The developments at Holland Capital in 2024 reflect our strong ambitions
Amsterdam/ Düsseldorf, 30th of December 2024 –The developments at Holland Capital in 2024 reflect our strong ambitions. Guided by a focused investment strategy, we continued to actively engage in the high-growth markets of Technology, Healthcare, and Agrifood. Reflecting on a successful year, we completed several key transactions and further strengthened our team.
2024 achievements
- The launch of our fund, Holland Capital Growth and Buy-Out Fund V
- Number of deals in the Netherlands: 5
- Number of add-on acquisitions in the Netherlands: 13
- Number of add-on acquisitions in Germany: 2
- Number of exits: 2
- Number of new colleagues: 4
Sector focus and an entrepreneurial hands-on approach: With specialized sector teams, we focus on the sectors of Healthcare, Technology, and Agrifood, both within the Growth & Buy-out and Venture & Growth segments. We understand the dynamics and opportunities in these sectors and have an extensive network. Holland Capital is not a passive investor; we work closely with management to define and execute strategies. Where needed, our operational team also contributes hands-on to the realization of specific projects within the company.
Which companies would we like to connect with?
- Sector: Technology, Healthcare, and Agrifood
- Positive outlook: Significant growth potential, both autonomous and buy-and-build
- Growth & Buy-out:
- Healthy profitability: cash flow from operations (EBITDA) between EUR 1 – 10m
- Smaller companies: considered as add-on acquisitions for our existing portfolio companies
- Larger companies: considered together with a co-investor
- Venture & Growth:
- Start-ups and scale-ups: EBITDA EUR <1m
- Cash flow negative (in an accelerated growth scenario)
- Revenue EUR 0 – 5m
What to expect from us?
- Flexible approach to transaction structures: We strive to adapt each structure to the needs of the company and its shareholders. Depending on the type of investment, Holland Capital either provides growth capital and/or acquires existing shares. We are flexible regarding the final capital structure: both majority and minority stakes are possible.
- Deal certainty and an efficient process: Thanks to our sector expertise, we are able to quickly assess a business model and put a fair price on the table. Since the partnership with the entrepreneur and/or the management team is the cornerstone of our investment, we devote above-average attention to ensuring the process is completed efficiently, in the right spirit, and with mutual respect for both parties.
- Transparency towards advisors: We appreciate it when advisors involve us early in discussions with entrepreneurs and/or management teams. In such cases, we always ensure that the advisor’s interests are well safeguarded throughout the process. The advisor retains the flexibility to decide whether to represent the sell-side or buy-side in a potential transaction.
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare, Technology, and Agrifood-Tech sector.
Portfolio onderneming Inno4Life verkocht aan het Zwitserse bedrijf Dec Group
Portfolio onderneming Inno4Life verkocht aan het Zwitserse bedrijf Dec Group Amsterdam, 16 april 2020 - Eerder deze maand is Inno4Life, een fabrikant van machines voor de farmaceutische industrie, verkocht aan het Zwitserse bedrijf Dec Group. Het management van...
Durfkapitaal voorziet massale faillissementen Nederlandse techbedrijven
Durfkapitaal voorziet massale faillissementen Nederlandse techbedrijven Door de uitbraak van het coronavirus zitten veel Nederlandse techbedrijven in geldnood. In het kort Jonge technologiebedrijven raken door de crisis snel door hun geld heen. Ze komen niet in...
VWS kiest ook voor Evone® van Ventinova uit Eindhoven
VWS kiest ook voor Evone® van Ventinova uit Eindhoven Resultaten met FCV® uitgeruste beademingsapparatuur lijken veelbelovend Eindhoven, 2 april 2020 – Het Eindhovense bedrijf Ventinova Medical ontving vandaag goed nieuws; het betreft een substantiële order voor de...
Dutch Ministry of Health also opts for Evone® by Ventinova from Eindhoven
Dutch Ministry of Health also opts for Evone® by Ventinova from EindhovenResults of FCV®-equipped ventilation equipment appears promising Eindhoven, 2 April 2020 – Ventinova Medical, a company based in Eindhoven, received good news today; this concerns a substantial...
Cloud service provider Eshgro zet volgende stap in groei door kapitaalinjectie Holland Capital
Cloud service provider Eshgro zet volgende stap in groei door kapitaalinjectie Holland Capital Boxmeer/Amsterdam, 24 maart 2020 - Participatiemaatschappij Holland Capital vergroot haar belang in Cloud service provider Eshgro. Door deze stap kan het in Boxmeer en...
Cloud service provider Eshgro receives capital injection from Holland Capital to accelerate further growth
Cloud service provider Eshgro receives capital injection from Holland Capital to accelerate further growth Boxmeer / Amsterdam, March 24, 2020 - Investment company Holland Capital has increased its interest in cloud service provider Eshgro. Based in both Boxmeer and...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl